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BACKGROUND: The association between caffeine with blood pressure (BP) still remains controversial. Caffeine is mainly metabolized by 
cytochrome-P450 (CYP)1A2 enzyme. Polymorphism of 
CYP1A2 is known to cause interindividual variation on 
enzymatic activity, thus affects caffeine metabolism and its 
effect on cardiovascular (CV) system. 
METHODS: We conducted a cross-sectional study and 
recruited 121 Indonesian subjects aged 25-60 years with 
varying coffee-drinking habits. DNA was extracted from 
peripheral blood and genotyped by polymerase chain 
reaction-restriction fragment length polymorphism (PCR-
RFLP) technique. Blood pressures were measured in 
the morning   prior   to   the   daily  activity.  Caffeine 
concentration  in  blood  plasma  was  measured  using 
high-performance liquid chromatography (HPLC). The 
differences between variables  were analyzed  using  Mann-
Whitney  analysis  and  the  correlations  among  variables 
were  determined  using multivariate logistic regression 
analysis. 
RESULTS: This study showed that the frequencies of 
single nucleotide polymorphisms (SNPs) among Indonesian 
were 31.8%, 18.2%, 25.2% and 24.8% respectively for 
CYP1A2*1A, CYP1A2*1B, CYP1A2*1C and CYP1A2*1F 
alleles. The genotype analysis showed that the subject 
number of the wild type (*1A/*1A) and the variants were 
9.92% and 90.08%. There were no significant differences 
in term of BP levels among CYP1A2 genotypes and coffee 
drinking habit groups. 
CONCLUSION: The frequencies of CYP1A2 SNPs 
in Indonesian are different with frequencies in other 
populations. Since the association were not statistically 
significant, CYP1A2 polymorphisms as the predictor of 
elevated blood pressuare should be investigated further.  
KEYwORDS: coffee, caffeine, blood pressure, single 
nucleotide polymorphism, CYP1A2
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Abstract
Introduction
More than 80% of the world’s population consumes caffeine 
(1,3,7-trimethylxanthine)-contained coffee, tea and soft 
drinks daily.(1) The effects of caffeine consumption on 
blood pressure (BP) and risk of cardiovascular diseases 
(CVD) have been widely reported. However, the results 
were inconsistent and still controversial. Although most 
cohort studies do not show significant associations between 
caffeine consumption and CVD, case-control studies tend to 
support significant associations.(1-3)
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 Caffeine is rapidly absorbed from gastrointestinal 
tract into the bloodstream. Approximately 95% of caffeine 
is metabolized by cytochrome P450 1A2 (CYP1A2).(4) 
The CYP1A2 enzyme is expressed primarily in liver and 
is responsible for oxidative metabolism of drugs such as 
theophylline, mexiletine, clozapine and phenacetin.(5,6) 
CYP1A2 genetic polymorphisms were known to cause 
interindividual variability on enzymatic activity.  Up to 60-
fold interindividual variation in CYP1A2 activity had ever 
been reported, including CYP1A2*1B, CYP1A2*1C and 
CYP1A2*1F (Figure 1). It is suggested that approximately 
35 to 75% of the interindividual variability of CYP1A2 
activity is due to genetic factors.(7,8) 
 Since interindividual variability of CYP1A2 gene is 
suggested to affect to BP elevation in substantial manner 
and frequency of CYP1A2 polymorphisms in Indonesia 
have not been characterized yet, therefore we aim to study 
the variability of CYP1A2 gene among Indonesian and its 
effect on BP.
Figure 1. Approximate location of CYP1A2*1B, CYP1A2*1C and CYP1A2*1F SNPs. Figure  is not scaled.
Methods
Study Design
A cross-sectional study was conducted from May 23, 2012, 
until June 5, 2013. Initially 130 patients were enrolled; 
finally, 121 subjects aged 25-60 years with varying coffee-
drinking habits participated in the study. All subjects had 
given full informed consent to participate. Ethical approval 
was obtained from the Health Research Ethics Committee, 
Faculty of Medicine, Universitas Hasanuddin, Makassar, 
Indonesia (0566/H4.8.4.5.31/PP36-KOMETIK/2010). 
Subjects
The subjects were enrolled from those who came to Prodia 
Clinical Laboratory in Denpasar and Jakarta, Indonesia, 
for having general medical check-up. All subjects were 
apparently in healthy conditions and willing to participate 
in the study. Subjects who were routinely consuming either 
vitamins or anti-inflammatory drugs, had kidney dysfunction 
(GFR <60 mL/min), diabetics (fasting glucose ≥126 mg/
dL), had abnormal liver function (ALT/AST >2x reference 
range) and acute inflammation (hsCRP >10 mg/dL) were 
excluded from the study. Subjects with waist circumference 
(WC) of more than 90 cm (man) or 80 cm (woman) and 
current smokers were excluded from the study as well.
Demographic Data and Questionnaire
All  tests  were  conducted  in the morning prior to any 
physical activity. After the consent process, subjects were 
provided and completed a validated questionnaire. The 
questionnaire was used to assess subject’s demographic 
data, past medical history, dietary intakes and coffee-
drinking habits.
Anthropometric and Blood Pressure Measurement
Body weight (BW) was quantified in kilograms to the nearest 
0.1 kg. Height and WC were measured in centimeters to the 
nearest 0.1 cm. WC was determined using a flexible non-
elastic tape made by Roche (Roche, Basel, Switzerland). It 
was measured at the midway region between the lowest rib 
margin and the iliac crest, in standing position, abdomen 
relaxed, feet close together and weight equally divided over 
both legs.
 Blood pressure was measured using calibrated 
sphygmomanometer and taken by trained healthcare 
professionals (nurses and physicians) who were instructed 
to follow standard procedures for BP measurement. An 
elevated BP reading was defined as a systolic BP ≥140 mm 
Hg or diastolic BP ≥90 mm Hg. 
Blood Analysis
Fasting  blood  samples  were  collected  in  the  morning  after 
the subjects completed questionnaire and anthropometric 
measurement. Serum was used for analysis of fasting blood 
glucose, creatinine, hsCRP, and liver function. Peripheral 
blood samples prepared with EDTA was used for genotype 
analysis  and caffeine concentration measurement.
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Genotype Analysis
Genomic DNA material was extracted from 5 mL of 
EDTA blood using High Pure PCR Template Preparation 
Kit (Roche Applied Science, Mannheim, Germany). DNA 
extracts were stored at -80oC prior to analysis. 
 Three polymorphisms were carried out; -1545T>C 
(CYP1A2*1B allele, rs2470890), -3860G>A (CYP1A2*1C 
allele, rs2069514) and -163C>A (CYP1A2*1F allele, 
rs762551). The polymerase chain reaction-restriction 
fragment  length  polymorphism  (PCR-RFLP) technique 
was   adopted   from  Sachse’s   and   Tiwari’s   method 
(Table 1).(9,10)
 Mastermix reagent contained namely: 2.5µL reaction 
buffer, 1.25mM MgCl2, 0.2mM dNTPs (100mM dNTP 
Set, Roche Applied Science), 0.25µL of each primers (1st 
Base, Singapore), AmpliTag Gold DNA Polymerase (Roche 
Applied Science) for *1B, Kappa 2G Robust PCR Kit 
(Kappa Biosystem, Cape Town, SA) for *1C and *1F, DMSO 
(Applied Biosystems, Foster City, CA, USA), template and 
PCR grade water. Amplification was performed in Veriti 
Analyzer (Applied Biosystems).
 According to RFLP method, the restriction enzymes 
were MluCI (New England Biolabs, Ipswich, MA, USA) 
for *1B, BslI (New England Biolabs) for *1C and PspOMI 
(New England Biolabs) for *1F. Analysis of restriction 
fragment was performed on 2% agarose gels (Promega, 
Madison, WI, USA). Electrophoresis was carried out and 
documented using GelDoc XR (Biorad, Hercules, CA, 
USA) (Figure 2).  
Caffeine Concentration Measurement
 Caffeine concentration measurement was performed 
by using high-performance liquid chromatography (HPLC). 
Briefly, 1 mL blood plasma was added with 200 mL of 20 
mg/mL theophylline, 500 mL of  6M KOH, 5 mL of tert-
Butyl methyl ether and 2 g of Na2SO4. The solution was 
homogenized with a rotary shaker and centrifuged. Resulted 
organic phase was collected and freeze-dried with nitrogen. 
Dried sample was then analyzed with HPLC. The organic 
solvents used for mobile phases was acetonitrile with flow 
rate of 1 mL/min. Photodiode array detector was used 
with the maximum wavelength of 273 nm. Commercially 
available caffeine (Sigma-Aldrich, St. Louis, MO, USA) 
was used to establish a standard curve.
Data Analysis
 Data analysis was done using SPSS for Windows 
version 15 software (SPSS Inc., Chicago, IL, USA). 
Distributions of continuous variable were assessed for 
normality and equality of variance, subsequently using 
Kolmogorov-Smirnov and Leven’s tests. The differences 
between variables were analyzed using Mann Whitney 
test. All tests were considered one-sided and significant at 
p-value of <0.05. 
Results
One hundred and twenty-one subjects were genotyped for 
CYP1A2 polymorphism. According to the data shown in 
Table 2, the frequencies of CYP1A2*1A, *1B, *1C, and 
*1F were calculated to be 31.8% (77/242), 18.2% (44/242), 
25.2% (61/242) and 24.8% (60/242), respectively. The 
genotype analysis showed that the subject number of the 
wild type (*1A/*1A) and the variants were 9.92% and 
90.08%. The complete frequencies of CY1A2 genotype 
were listed in Table 2.
 Twenty-six of 121 subjects were excluded from the 
study due to various reasons and 95 subjects (Table 3) were 
still included in BP analysis. Table 4 presents the differences 
between CYP1A2 genotype, coffee drinking habits and BP 
levels. There were no significant differences in term of BP 
levels among CYP1A2 genotypes and coffee drinking habit 
groups. 
SNP Primer Sequence PCR Program Restriction Enzyme
Resulted Band 
(bp) Reference
F: AGCCCTTGAGTGAGAAGATG 35x C: 555
R: GGTCTTGCTCTGTCACTCA (30s 95oC – 30s 58 oC – 60s 72 oC) T: 425-130
F: GCTACACATGATCGAGCTATAC 35x G: 343-132-93 
R: CAGGTCTCTTCACTGTAAAGTTA (30s 95 oC – 30s 52 oC – 60s 72 oC) A: 475-93
F: TGAGGCTCCTTTCCAGCTCTCA 35x A: 265
R: AGAAGCTCTGTGGCCGAGAAGG (30s 95 oC – 30s 58 oC – 60s 72 oC) C: 211-54
CYP1A2*1F PspOM I 10
CYP1A2*1B MluC I 11
CYP1A2*1C Bsl I 10
Table 1. Primers and PCR conditions used for CYP1A2 genotyping. 
s: seconds.
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CYP1A2*1B
1 = C/C
2 = T/T
5 = C/T
CYP1A2*1C
5 = G/A
6 = G/G
15 = A/A
CYP1A2*1F
4 = A/C
5 = A/A
6 = C/C
Figure 2. CYP1A2*1B, 
CYP1A2*1C and CYP1A2*1F 
SNPs detection with PCR-
RFLP. L: ladder.
SNP n (%)
CYP1A2 *1A/*1A 12 (9.92)
CYP1A2 *1A/*1B 12 (9.92)
CYP1A2 *1A/*1C 20 (16.53)
CYP1A2 *1A/*1F 21 (17.36)
CYP1A2 *1B/*1B 2 (1.65)
CYP1A2 *1B/*1C 14 (11.57)
CYP1A2 *1B/*1F 14 (11.57)
CYP1A2 *1C/*1C 7 (5.79)
CYP1A2 *1C/*1F 13 (10.74)
CYP1A2 *1F/*1F 6 (4.96)
Table 2. CYP1A2 genotype in Indonesian population. (n total: 
121 subjects).
n: subject number.
Discussion
The frequencies of CYP1A2*1B (18.2%) and *1C (25.2%) 
in Indonesian are close to the reported frequencies in 
Japanese, whereas the frequency of *1F (24.8%) in 
Indonesian appears to be lower than that in Japanese. 
The frequencies of 19.2%, 23.6% and 62.8% for allele 
*1B, *1C, *1F in Japanese were reported by Soyama, et 
al.(5) Studies conducted by Nakajima, et al. and Chida, 
et al., showed that the frequencies of *1C and *1F alleles 
were 23.0% and 61.3% among Japanese.(11,12) The 
frequencies of *1C allele among Chinese were 21-25%.
(13-15) The *1A/*1A genotype was considered as wild type 
(extensive metabolizer) whereas the others as mutants (poor 
metabolizer).
 Table 2 showed the frequencies of CYP1A2 genotype 
in Indonesian. This study was only genotyped 3 sorts of 
CYP1A2 polymorphisms. Up to now, there were more 
than 40 CYP1A2 alleles (haplotype) published in Human 
Cytochrome P450 Allele Nomenclature Committee 
homepage (http://www.cypalleles.ki.se). 
 CYP1A2 enzyme is responsible for 95% of 
caffeine metabolism. Consequently, there is up to 60-fold 
differences in enzymatic activity among individual. This 
interindividual variability is due to genetic (35-75%) and 
environmental factors.(7,8) This enzymatic activity is 
also induced by various xenobiotic compounds, such as 
3-methylcholanthrene and other aromatic hydrocarbons. 
Smoking and heavy coffee drinking habits would have 
induced enzymatic activity, eventually BP rise.(16,17)
 In this study, we found that there were no significant 
differences in term of BP levels and caffeine level between 
CYP1A2 genotypes and coffee drinking habit groups 
(Table 4). The BP of variant group was higher than wild 
type group among coffee drinkers (SBP: 109.31 ± 10.19 
vs. 105.00 ± 5.77 mmHg; DBP: 73.63 ± 8.78 vs. 67.50 ± 
5.00 mmHg, respectively). The caffeine level was higher 
in variant group compared with wild type group (0.667 
± 0.81 µg/mL vs. 0.375 ± 0.44 µg/mL). Both the BP and 
caffeine measurements were carried out in the morning 
after overnight fasting (10-12 hour).(18) This overnight 
fasting possibly caused the caffeine level, as well as BP, 
getting back to normal levels. Thus, the time lag between 
exposure/consumption and BP measurements is important 
to determine the association between coffee consumption 
and BP. The influence of coffee consumption (caffeine) on 
BP may vary, from zero to several mmHg. Longer coffee 
abstinence may also decrease BP.(2,19,20) Interestingly, 
caffeine was also found in the sample of non-coffee drinker 
Print ISSN: 2085-3297, Online ISSN: 2355-9179The Indonesian Biomedical Journal, Vol.10, No.3, December 2018, p.297-302
301
Non-Coffee 
Drinker
Coffee 
Drinker Total
40 (42.1%) 55 (57.9%) 95 (100%)
Male 11 (11.6%) 22 (23.1%) 33 (34.7%)
Female 29 (30.5%) 33 (34.7%) 62 (65.3%)
37.62 ± 8.21 38.18 ± 7.52 37.95 ± 7.78
0 9.16 ± 7.95 -
Hypertension 19 (20.0%) 21 (22.1%) 40 (42.1%)
Diabetes mellitus 12 (12.6%) 12 (12.6%) 24 (25.3%)
19 (20.0%) 22 (23.2%) 41 (43.2%)
0 0 0
21 (22.1%) 32 (33.7%) 53 (55.8%)
Physical exercise
Alcohol consumption
Tea consumption
Variable
n (%)
Gender
Average age (years)
Average duration of coffee 
consumption (years)
Family history
Table 3. Subject characteristics.
n: subject number.
group, suggesting that subjects have consumed any caffeine-
contained meal or drink other than coffee, possibly tea and 
caffeinated soft drinks.
 Although being reported harmful, coffee contains 
beneficial compounds as an antioxidant, including 
chlorogenic acid, flavonoids, melanoidins and various lipid-
soluble compounds such as furans, pyrroles and maltol. 
Epidemiological studies revealed coffee is the main source 
of antioxidant.(21,22) The antioxidant compounds in coffee 
will be absorbed rapidly after ingestion and leads to increased 
circulating antioxidant levels. On the other hand, caffeine 
increases angiotensin II production by inhibiting adenosine 
A1 receptor.(23) Therefore, the balance between pro- and 
anti-oxidative compounds in coffee and inflammatory status 
may be important factors to affect BP.(24)
 Coffee consumption has become part of modern 
lifestyle factor, together with smoking and alcohol 
Wild Type Variant Wild Type Variant
Mean ± SD Mean ±  SD Mean ±  SD Mean ±  SD
n 4 36 - 4 51 -
Average age (years) 37.18 ± 8.38 37.67 ± 8.31 0.983 35.40 ± 3.20 38.41 ± 7.74 0.584
Caffeine (µg/mL) 0.21 ± 0.36 0.17 ± 0.23 0.778 0.375 ± 0.44 0.667 ± 0.81 0.542
SBP (mmHg) 107.50 ± 5.00 109.31 ± 13.53 0.948 105.00 ± 5.77 109.31 ± 10.19 0.370
DBP (mmHg) 75.00 ± 5.77 72.64 ± 7.88 0.557 67.50 ± 5.00 73.63 ± 8.78 0.175
Variable
Non-Coffee Drinker Coffee Drinker
p p
Table 4. CYP1A2 and blood pressure.
n: Subject number; SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood 
pressure.
consumption. Smoke was known to increase CYP1A2 
activity.(2,25) In this study we were just able to control 
some confounders such as; age, alcohol consumption, 
smoking habits, weight circumference, medical history 
(acute inflammation, hypertension, diabetes, renal failure) 
and dietary factors (antioxidant/vitamin/energy drinks 
consumption) by design. However, the method of coffee 
preparation (boiled and filtered), the type of coffee (black 
coffee and instant coffee), varieties of coffee (arabica and 
robusta) and the exact amounts of coffee ingested were 
technically arduous to be adjusted in the study. Furthermore, 
hypertension is a multifactorial disorder and involves 
multiple environmental and genetic determinants. Many 
genetic analyses have been performed in different ethnic 
population, but the result is still inconsistent and specific 
cause of hypertension remains unclear. Further study need 
to be done, especially the experimental study to examine the 
acute effects of coffee consumption and its association with 
CYP1A2 polymorphism. 
Conclusion
The frequencies of CYP1A2 SNPs in Indonesian are 
different with frequencies in other populations. Since the 
association were not statistically significant, CYP1A2 
polymorphisms as the predictor of elevated blood pressuare 
should be investigated further.  
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